For patients with Medicare, Medicare Part D or other government insurance plans, we can help identify potential financial support options.
Alternative Funding Sources
For those patients who need help with their medication cost-sharing requirements, Pfizer will refer patients who may be eligible to Medicare Extra Help or alternate sources of funding.
If support through an alternate funding source is not available, some patients may be eligible to receive VYNDAQEL at no cost through the Pfizer Patient Assistance Program (PAP).* Patients must reapply annually.
*Criteria depend on a number of factors, including the specific medicine prescribed, insurance status, and household size and income. The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and the Pfizer Patient Assistance Foundation™. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc., with distinct legal restrictions.